Widad inks agreement with Rinani


KUALA LUMPUR: Widad Group Bhd has signed a memorandum of collaboration with Rinani Dynamic Sdn Bhd for the distribution, marketing and selling of the Covid-19 vaccine.

In a statement Tuesday, Widad said Rinani is the local representative in Malaysia for VAXART Inc, an US-based entity that is listed on Nasdaq with respect to its ongoing development of an oral-based (tablet) Covid-19 vaccine.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Widad , Rinani , Vaxart , Covid-19

Next In Business News

Fahmi: Malaysia's economy remains strong, continues to be the focus of foreign investors
Carimin acquires 19.5% stake in Sealink International for RM40mil
TNB terminates renewable energy PPA with Reneuco
Sunway to proceed with RM11bil takeover of IJM
KIP-REIT expects higher footfall across its malls
Oxford Innotech wins RM4.8mil data centre job
Suria Capital appoints Abd Rahman Dahlan as chairman
Ringgit closes higher amid US-EU tariff concerns, easing Japanese government bonds
Shin Yang secures RM117.7mil vessel deal
UOA REIT reports threefold profit increase in 4Q25

Others Also Read